✦ LIBER ✦

Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor

✍ Scribed by M. Fernandez-Galar; A. España; J. M. López-Picazo

Book ID: 108692465
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 155 KB
Volume: 29
Category: Article
ISSN: 0307-6938
DOI: 10.1111/j.1365-2230.2004.01466.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Follicular and epidermal alterations in

Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor

✍ R. Van Doorn; G. Kirtschig; E. Scheffer; T.J. Stoof; G. Giaccone 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

We report the cutaneous side-effects of ZD1839 (Iressa), a new anticancer agent that acts by inhibiting epidermal growth factor (EGF) receptor signal transduction. Three patients receiving ZD1839 developed an eruption consisting of follicular papules and pustules in an acneiform distribution as well

The effect of ZD1839 (IressaTM), an epid

The effect of ZD1839 (IressaTM), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells

✍ A. Al-Hazzaa; I. D. Bowen; P. Randerson; M. A. Birchall 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

ChemInform Abstract: Studies Leading to

ChemInform Abstract: Studies Leading to the Identification of ZD1839 (Iressa): An Orally Active, Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Targeted to the Treatment of Cancer.

✍ Keith H. Gibson; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 29 KB 👁 2 views

A novel approach in the treatment of neu

A novel approach in the treatment of neuroendocrine gastrointestinal tumours. Targeting the epidermal growth factor receptor by gefitinib (ZD1839)

✍ Höpfner, M; Sutter, A P; Gerst, B; Zeitz, M; Scherübl, H 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 242 KB

N-Glycan fucosylation of epidermal growt

N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor

✍ Kazuko Matsumoto; Hideyuki Yokote; Tokuzo Arao; Mari Maegawa; Kaoru Tanaka; Yosh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Gefitinib (‘Iressa’, ZD1839) inhibits th

Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2

✍ Nutt, J E; Lazarowicz, H P; Mellon, J K; Lunec, J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB